男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

抗前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)單克隆抗體

Anti-Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Monoclonal Antibody

FH3; HCHOLA3; NARC1; Hypercholesterolemia,Autosomal Dominant 3; Neural apoptosis-regulated convertase 1; Proprotein convertase 9; Subtilisin/kexin-like protease PC9

  • 抗前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)單克隆抗體產(chǎn)品包裝(模擬)
  • 抗前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)單克隆抗體產(chǎn)品包裝(模擬)
  • 抗前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)單克隆抗體Mouse Hepa1-6 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 10μg/ml mouse Anti-rat PCSK9 Monoclonal Antibody (Catalog FAE189Ra02, red histogram) or Isotype control antibody (Catalog IS067-Mu03, green histogram), followed by 1μg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
  • Certificate通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

用法

Flow cytometry: 10μg/ml;
Optimal working dilutions must be determined by end user.

儲(chǔ)存

經(jīng)常使用則4°C保存。-20°C保存不超過一年。避免反復(fù)凍融。

贈(zèng)品

相關(guān)產(chǎn)品

編號(hào)適用物種：Rattus norvegicus (Rat，大鼠)應(yīng)用(僅供研究使用，不用于臨床診斷！)
RPE189Ra01前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAE189Ra01前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)多克隆抗體WB; IHC; ICC; IP.
MAE189Ra23前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)單克隆抗體WB; IHC; ICC; IP.
MAE189Ra22前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)單克隆抗體WB; IHC; ICC; IP.
MAE189Ra21前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)單克隆抗體WB; IHC
FAE189Ra02抗前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)單克隆抗體Flow cytometry.
SEE189Ra前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)Enzyme-linked immunosorbent assay for Antigen Detection.
LME189Ra前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)等多因子檢測試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志參考文獻(xiàn)
Biological Trace Element ResearchSynergistic Cardioprotective Effects of Combined Chromium Picolinate and Atorvastatin Treatment in Triton X-100-Induced Hyperlipidemia in Rats: Impact on Some Biochemical Markers[pubmed:28409410]
BASIC RESEARCH IN CARDIOLOGYAutocrine effects of PCSK9 on cardiomyocytes[Pubmed: 33169229]
J Transl MedMulti-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans[33407555]
MetabolismMiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice[33775647]
Eur Rev Med Pharmacol SciAssociation of serum proprotein convertase Subtilisin/Kexin Type 9 (PCSK9) level with thyroid function disorders[34533801]
Clin Exp HypertensProprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet's disease[Pubmed:35502687]